Article
Mutations in human O6-alkylguanine-DNA alkyltransferase imparting resistance to O6-benzylguanine.
Cancer research - 1 Dec 1994
Crone T M, Goodtzova K, Edara S, Pegg A E
Abstract excerpt
O6-Benzylguanine is an inactivator of O6-alkylguanine-DNA alkyltransferases (AGT) which is currently entering clinical trials as an agent improving the cancer chemotherapeutic activity of chloroethylnitrosoureas and other alkylating agents. O6-Benzylguanine acts by virtue of its ability to serve as a substrate for the AGT forming S-benzylcysteine at the cysteine acceptor site. The effects of a number of mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
